Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells. - Wikidata - wikimedia - TriplyDB

Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.

Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.

http://www.wikidata.org/entity/Q36796668

about

GPER Function in Breast Cancer: An Overview The G-protein-coupled estrogen receptor GPER in health and disease GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells Copper activates HIF-1α/GPER/VEGF signalling in cancer cells Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30.Mechanisms of estrogen signaling and gene expression via GPR30 GPCRs and cancer The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma Highly efficient synthesis and characterization of the GPR30-selective agonist G-1 and related tetrahydroquinoline analogs.Co-expression of GPR30 and ERbeta and their association with disease progression in uterine carcinosarcoma.ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches GPR30, the non-classical membrane G protein related estrogen receptor, is overexpressed in human seminoma and promotes seminoma cell proliferation.MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer.Differential roles of ERα and ERβ in normal and neoplastic development in the mouse mammary gland The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytes GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signals Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα)Estrogen action and prostate cancer.Novel Aspects Concerning the Functional Cross-Talk between the Insulin/IGF-I System and Estrogen Signaling in Cancer Cells.Activation of GPR30 inhibits cardiac fibroblast proliferation.Low concentrations of bisphenol A induce mouse spermatogonial cell proliferation by G protein-coupled receptor 30 and estrogen receptor-α.International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models.Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma.The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.Stimulation of GPR30 increases release of EMMPRIN-containing microvesicles in human uterine epithelial cells.G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts.Differences in GPR30 Regulation by Chlorotriazine Herbicides in Human Breast Cells Derailed estrogen signaling and breast cancer: an authentic couple.Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling.Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPER The G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Nuclear Estrogen Receptor Activity and Stimulates Novel Phosphoproteomic Signatures Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs)Potential of olive oil phenols as chemopreventive and therapeutic agents against cancer: a review of in vitro studies.

P2860

Q21131274-AB44B871-9BEF-4148-B8B4-E953FE296DCA Q27013052-0FBCC151-1869-4221-AFD1-156B1D9ACEC2 Q27340035-CC04BAED-A09E-4512-B4BC-1A1A5544394B Q28386629-C844FBCA-E22C-4D4A-A831-64EFE40FF960 Q28601324-C7F845FA-005C-439F-B9CD-9DE57C713632 Q33640444-78272B6B-C368-453F-94BA-2B4C9C3C5A5B Q33760458-2EEA0BBD-D9D1-44CD-BBF7-504791691C85 Q33828719-3C060F17-0897-48EC-BEE3-D39451322DD0 Q33888243-BCAC8B60-101D-4C7D-B8AC-D2126C1CC566 Q33898496-D2F02269-F7FE-4759-B4D9-586925F8E33A Q34033184-810B0988-6691-48B1-896B-49AB4881CC79 Q34106472-7D0DF5CC-0054-496A-A526-FDF52F80BD8D Q34119028-4D4BFE65-06F5-489A-9D97-5B426C3ABD79 Q34230244-A3377214-6F6F-45C4-B4AA-074D50FC3585 Q34247686-65DB3348-6B4C-4F0E-8589-55EC5C6FDE14 Q34518031-F17F2D5A-43AB-42BD-BE15-2C40C8856B7E Q34535857-ACB0F309-CD91-4CBC-B48C-D49A2B41B101 Q34696040-29815BCA-D0F5-4E4A-810D-4F066F06420F Q34696884-A56AAE3D-F1A9-4FD1-B56A-AC7528CA1ED5 Q34988724-D8F5C58E-28EF-4B73-BBB5-13FD92417F1B Q35099011-9418D691-1779-4675-8325-BBF84AE15B71 Q35153546-FDF474F6-72B4-400E-AF89-828CE1982274 Q35666086-BD024D5D-10FD-4F83-BD2E-097FC878DC32 Q35682920-7E54F6AF-1D54-442D-990B-C95A0D1C9B83 Q35795751-25847EF3-3724-4729-9D7D-AB4FD4FED7D6 Q36095938-E87E6C4A-BB1C-435D-8391-4DCF45083392 Q36175376-6BD8216A-F6E7-4390-8FD7-A2C127E5695A Q36261733-D7DFF197-8E87-48A6-84FB-F2FD67B32AB9 Q36291117-257EAF51-3B7F-4814-A48C-8B92788D73C2 Q36293908-589F2941-0161-458C-9ACF-ABA23F0E6AA4 Q36442398-E12CBECF-D0AD-4F75-9079-FB1E841D35A7 Q36481702-9EEFA335-F049-40BD-BAC1-1D5E2FA1DB23 Q36587317-C6C619E2-348D-426B-A5A5-A641E44BF3BA Q36589361-01F7086D-4434-4612-B147-16CD884FA131 Q36653897-8C317A2B-D3CF-4E32-AB8C-FFFC6188B70F Q36800401-BD6DC40E-8BC6-453A-8F46-C8DECB215874 Q36935460-40AE4B57-272F-43D0-8362-542DA952F0B5 Q37133153-7955D8BC-A60E-4897-BFBD-6DB57E9908AD Q37690722-CE681672-3F7C-44D8-8020-46E7320389CD Q38063484-C7B3E4D3-298C-47C8-8CD6-76F4A6B2E1B8

P2860

Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.

http://www.wikidata.org/entity/Q36796668

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Epidermal growth factor induce ...... -negative breast cancer cells.

@en

type

label

Epidermal growth factor induce ...... -negative breast cancer cells.

@en

prefLabel

Epidermal growth factor induce ...... -negative breast cancer cells.

@en

P1433

Q36796668-8EF098B9-E3F1-4023-BC80-B9D43370FD1C

P1476

Q36796668-B27382AF-E715-4444-9D37-D329D94DED1A

P2093

Q36796668-241C2861-B56E-47C7-BC2B-0475EF10D468

Q36796668-3177894B-DB23-4369-8EA5-2832DEA87A64

Q36796668-5B3DBCDF-1AF5-4810-9A7D-1A09A54658FD

Q36796668-5F3DFDE8-CA78-4D1C-96BB-4483D9BF4BA9

Q36796668-63BBF4D3-10C2-494D-8B49-C5A066050234

Q36796668-7B63359A-C695-4974-9EA2-EA9C0C580ED5

Q36796668-AAA77860-F954-482C-8336-4B570C8FE66D

Q36796668-B91384E9-FB46-4772-9C28-67C74650094B

Q36796668-CA37D9EC-D553-41B8-9362-E3972BE1CA06

Q36796668-E468BCA0-0A5B-4DDB-AEA7-9699A06296D3

P2860

Q36796668-10FCBF2C-BF53-4162-8714-B79058819EC1

Q36796668-13C1D225-388C-4726-B79E-A686855DF6FC

Q36796668-1402C8B9-E603-4476-9804-67AEEC7E5BCD

Q36796668-18A2DA32-DC02-412F-B31F-FBBB2D2E7DC1

Q36796668-1A0E3167-2DB5-4163-BFFD-B3E256CA2905

Q36796668-262BDB62-5977-487A-9A60-C8A34A60AB3E

Q36796668-2DE6F5EE-ACE3-4816-859E-B9D4085BB5B8

Q36796668-3A1DD14C-7D31-4D90-8BFC-B92973307A1D

Q36796668-4A8F94FF-FAE5-4C0A-8B63-68DBB286F4AF

Q36796668-4D5F7B40-2C0D-4C03-AD16-1A7D3F4AB439

P304

Q36796668-0BE62865-51DF-4058-AEB0-F9BD389D7BC2

P31

Q36796668-7DEFA06E-88FB-4F75-925D-60C02C254D19

P356

Q36796668-0BB58178-05D9-48AA-9E85-2BF3DFEA2BEB

P407

Q36796668-8B229F90-49E4-498A-8753-903D65D09F2D

P433

Q36796668-BB41C63D-5317-4A75-B0D6-E63C407D318A

P478

Q36796668-88E2D86C-C1B0-4DE0-8E68-8D604DA49E8A

P50

Q36796668-B55D307B-3370-4DFC-A679-4F5405A8093A

P577

Q36796668-7EEAD1CA-12B2-41A4-B903-C3228D02EFC4

P5875

Q36796668-895206BD-07CE-47DD-9879-50ABD53785DC

P698

Q36796668-14303A83-3DDB-4F65-9A32-A9503BDD70E3

P921

Q36796668-57D66BE1-A8DF-481E-BE8E-FFA1F889F8FE

Q36796668-7CF44363-548E-4ADB-AC2E-7B09A3A18655

P932

Q36796668-BF280537-C46F-4819-80FF-DF40FA7DC93A

P356

P1433

P1476

Epidermal growth factor induce ...... -negative breast cancer cells.

@en

P2093

Adele Vivacqua

http://www.w3.org/2001/XMLSchema#string

Antonio Madeo

http://www.w3.org/2001/XMLSchema#string

Deo Prakash Pandey

http://www.w3.org/2001/XMLSchema#string

Didier Picard

http://www.w3.org/2001/XMLSchema#string

Elvira Brunelli

http://www.w3.org/2001/XMLSchema#string

Lidia Albanito

http://www.w3.org/2001/XMLSchema#string

Loredana Mauro

http://www.w3.org/2001/XMLSchema#string

Marcello Maggiolini

http://www.w3.org/2001/XMLSchema#string

Rosamaria Lappano

http://www.w3.org/2001/XMLSchema#string

Saveria Aquila

http://www.w3.org/2001/XMLSchema#string

P2860

A transmembrane intracellular estrogen receptor mediates rapid cell signaling

Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells

Integration of the extranuclear and nuclear actions of estrogen

Lysophospholipids--receptor revelations

Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells

Regulation of epidermal growth factor receptor by estrogen

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF

AP-1 as a regulator of cell life and death

EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF

P304

3799-3808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/EN.2008-0117

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

149

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5385118

http://www.w3.org/2001/XMLSchema#string

P698

18467441

http://www.w3.org/2001/XMLSchema#string

P921

estrogen-receptor negative breast cancer

G protein-coupled receptor

P932

2488235

http://www.w3.org/2001/XMLSchema#string